| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients (NCT05252078) | Jiangxi Provincial Cancer Hospital | 2022-06-02 |
| EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC (NCT05150236) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2022-04-29 |
| OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. (NCT04493632) | OncoSil Medical Limited | 2022-04-12 |
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations (NCT05241873) | Blueprint Medicines Corporation | 2022-03-04 |
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC (NCT05153408) | Blueprint Medicines Corporation | 2022-01-13 |
| Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy (NCT05022667) | University of Michigan | 2021-12-01 |
| Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma (NCT04572451) | Yana Najjar | 2021-11-29 |
| Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer (NCT04807166) | Wenjun Cheng | 2021-08-24 |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC (NCT04862780) | Blueprint Medicines Corporation | 2021-06-29 |
| Spanish Series of Patients Treated With the Radionuclide Lutetium177 (NCT04949282) | Sociedad Española de Medicina Nuclear e Imagen Molecular | 2021-05-10 |
| High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy (NCT04461509) | Alessandro D'Agnolo | 2021-04-06 |
| The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients (NCT03003195) | University of Arkansas | 2021-03-01 |
| External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC (NCT04697446) | Blueprint Medicines Corporation | 2020-12-01 |
| Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial (NCT04679675) | Kaiser Permanente | 2020-11-20 |
| Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071) | Xiaoxiang Chen | 2020-11-06 |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases (NCT05322486) | State Scientific Centre of Coloproctology, Russian Federation | 2020-10-29 |
| Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NCT04566952) | Xiaoxiang Chen | 2020-10-28 |
| Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study (NCT05602935) | The Second Affiliated Hospital of Fujian Medical University | 2020-09-16 |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04222972) | Hoffmann-La Roche | 2020-07-24 |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) (NCT04249947) | Poseida Therapeutics, Inc. | 2020-02-28 |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients (NCT04080843) | Zhejiang University | 2019-11-15 |
| HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors (NCT03911388) | M.D. Anderson Cancer Center | 2019-09-12 |
| Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer. (NCT04061967) | Karolinska Institutet | 2019-08-19 |
| Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma (NCT04124198) | Christian von Buchwald | 2019-03-01 |
| A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) (NCT03656718) | Bristol-Myers Squibb | 2018-10-29 |
| Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies (NCT03569605) | UNC Lineberger Comprehensive Cancer Center | 2018-08-23 |
| Savolitinib vs. Sunitinib in MET-driven PRCC. (NCT03091192) | AstraZeneca | 2017-07-25 |
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC (NCT03134872) | Jiangsu HengRui Medicine Co., Ltd. | 2017-05-12 |
| International Lung Screen Trial (ILST) (NCT02871856) | The University of Queensland | 2017-04-05 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer (NCT02960724) | Rigshospitalet, Denmark | 2016-11-01 |
| Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised Specimen (NCT05113134) | Seoul National University Bundang Hospital | 2015-03-02 |
| A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts (NCT02266745) | Promontory Therapeutics Inc. | 2014-07-01 |
| Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) (NCT01964430) | Celgene | 2014-03-28 |
| A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy (NCT02111824) | The Methodist Hospital Research Institute | 2014-01-05 |
| An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors (NCT01968109) | Bristol-Myers Squibb | 2013-11-05 |
| Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC (NCT01917279) | Binghe Xu | 2013-10-01 |
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial (NCT01995942) | Royal Marsden NHS Foundation Trust | 2013-06-07 |
| Protection of Rectum From High Radiation Doses Using a Spacer (NCT01918605) | University of Oulu | 2013-06-01 |
| Safety Study of IL-21/Anti-PD-1 Combination in the Treatment of Solid Tumors (NCT01629758) | Bristol-Myers Squibb | 2012-06-01 |
| A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients (NCT01576380) | Novartis Pharmaceuticals | 2012-06-01 |
| ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer (NCT01472146) | Susanne Crocamo | 2011-10-01 |
| The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction (NCT01427400) | University of British Columbia | 2011-10-01 |
| Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01009593) | Abbott | 2010-01-01 |
| Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks (NCT01037049) | Royal Marsden NHS Foundation Trust | 2009-10-16 |
| Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue (NCT01043913) | Faculdade de Medicina do ABC | 2008-02-01 |
| Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients (NCT00562224) | Pharmacyclics LLC. | 2007-11-01 |
| Low Rectal Cancer Study (MERCURY II) (NCT02005965) | Royal Marsden NHS Foundation Trust | 2007-08-13 |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer (NCT00377520) | Eli Lilly and Company | 2006-09-01 |
| Studying Normal Breast Tissue and Cancer Risk (NCT00341692) | National Cancer Institute (NCI) | 2003-04-07 |
| A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer (NCT00050427) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-12-01 |
| A Study of Trabectedin in Patients With Advanced Ovarian Cancer (NCT00050414) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2002-10-01 |
| Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer (NCT00384891) | Medical Enterprises Europe B.V. | 2002-02-01 |
| Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLC (NCT06841874) | Nuvation Bio Inc. | |
| SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I (NCT02254915) | Medical Enterprises Europe B.V. | |